Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers
- PMID: 11891539
Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers
Abstract
Head and neck cancer is a frequent malignancy with a complex, and up to now not clear etiology. The reactivation of telomerase activity and losses or gains of specific chromosomal regions, which point to deletions of tumor suppressor genes or amplification of oncogenes are supposed to be the molecular processes during the development and progression of head and neck cancer. Therefore, we analyzed telomerase activity and microsatellite markers using a genome wide panel of 28 microsatellite markers in 38 head and neck squamous-cell carcinomas (HNSCC). Our microsatellite marker set included distinct chromosomal areas that all likely harbor genes contributing to the carcinogenesis of HNSCC. DNA or protein lysates were obtained from primary tumors and compared to peripheral lymphocytes or corresponding normal tissue. At least one genomic alteration [loss of heterozygosity (LOH), or microsatellite instability (MSI)] was found in 31 of the 38 cases (82%). Most frequently we detected an LOH in the chromosomal region 9p12-21 where at least the tumor suppressor genes (TSG) p16INK4A, p14ARF and p15INKB are localized. The comparison between grade two and grade three tumors showed a highly changed frequency of LOH in the chromosomal region 7q31, where a putative TSG is predicted. Telomerase activity was present in 31/37 (83.8%) tumor samples independent of the histopathological staging and grading of the tumors. These molecular characterizations of HNSCC may be a further hint for the involvement of additional, so far unknown, TSGs in the tumor progression and will elucidate the regulation of telomerase.
Similar articles
-
Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.Oncogene. 2002 Jun 27;21(28):4462-70. doi: 10.1038/sj.onc.1205540. Oncogene. 2002. PMID: 12080476
-
Deletion mapping of chromosome 4q22-35 and identification of four frequently deleted regions in head and neck cancers.Neoplasma. 2008;55(4):299-304. Neoplasma. 2008. PMID: 18505340
-
Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene.Cancer Res. 1995 Mar 15;55(6):1347-50. Cancer Res. 1995. PMID: 7882334
-
The clinical relevance of microsatellite alterations in head and neck squamous cell carcinoma: a critical review.Eur J Hum Genet. 2007 Jul;15(7):734-41. doi: 10.1038/sj.ejhg.5201845. Epub 2007 May 2. Eur J Hum Genet. 2007. PMID: 17473833 Review.
-
Genomic instability in squamous cell carcinoma of the head and neck.Anticancer Res. 1996 Jul-Aug;16(4C):2421-31. Anticancer Res. 1996. PMID: 8816845 Review.
Cited by
-
Impairment of MLH1 and CDKN2A in oncogenesis of laryngeal cancer.Br J Cancer. 2004 Apr 19;90(8):1594-9. doi: 10.1038/sj.bjc.6601679. Br J Cancer. 2004. PMID: 15083191 Free PMC article.
-
ATM in oral carcinogenesis: association with clinicopathological features.J Cancer Res Clin Oncol. 2008 Sep;134(9):1013-20. doi: 10.1007/s00432-008-0365-7. Epub 2008 Feb 21. J Cancer Res Clin Oncol. 2008. PMID: 18288488 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous